- Vial
Generic Name & Amount | Pack Sizes | Indications |
---|---|---|
Each Vial Contains: Ceftazidime pentahydrate Equivalent to anhydrons Ceftazidime 250 mg, 500 mg or 1gm. | Vial: One Vial | • Treatment of single or multiple infections caused by susceptible organisms. • Severe infections e.g. septicaemia, bacteraemia, peritonitis meningitis. • Infections in immunosuppressed patients. • Infections in patients in intensive care e.g. infected burns. • Respiratory tract infections including lung infections in cystic fibrosis. • Ear, nose and throat infections. • Urinary tract infections. • Skin and soft tissue infections. • Gastrointestinal, biliary and abdominal infections. • Bone and joint infections. • Infections associated with haemo- and peritoneal dialysis and with continuo us ambulatory peritoneal dialysis (CAPD). • Prophylaxis: prostatic surgery (transurethral resection). |
- Vial
GENERIC NAME & AMOUNT
Each Vial Contains:
Ceftazidime pentahydrate
Equivalent to anhydrons Ceftazidime
250 mg, 500 mg or 1gm.
PACK SIZES
Vial:
One Vial
INDICATIONS
- Treatment of single or multiple infections caused by susceptible organisms.
- Severe infections e.g. septicaemia, bacteraemia, peritonitis meningitis.
- Infections in immunosuppressed patients.
- Infections in patients in intensive care e.g. infected burns.
- Respiratory tract infections including lung infections in cystic fibrosis.
- Ear, nose and throat infections.
- Urinary tract infections.
- Skin and soft tissue infections.
- Gastrointestinal, biliary and abdominal infections.
- Bone and joint infections.
- Infections associated with haemo- and peritoneal dialysis and with continuous ambulatory peritoneal dialysis (CAPD).
- Prophylaxis: prostatic surgery (transurethral resection).